ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974

NIH Changes SBIR/STTG Application Receipt Dates.

February 18, 2000

Bush Proposes $27.9 Billion for NIH, Plus $1.4B Reprogram From FY03

February 7, 2003

ORI Finds Misconduct By CIT Professor

August 4, 1995

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005

In Brief: NCAB Okays Columbia As 21st Comprehensive Cancer Center; GA Probes Cancer Control

February 23, 1979